Rigel Pharmaceuticals, Inc. (RIGL)

Rigel Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	24.41	40.58	56.75	32.79	24.46	18.89
Short-Term Investments	122.27	114.38	20.58	24.15	33.75	106.08
Cash & Short-Term Investments	146.68	154.96	77.32	56.93	58.21	124.97
Cash Growth	90.25%	100.41%	35.81%	-2.19%	-53.42%	117.99%
Accounts Receivable	49.95	51.76	41.62	30.55	40.32	15.47
Inventory	11.65	11.51	6	5.52	9.12	6.62
Other Current Assets	25.75	21.94	10.17	6.26	8.26	7.41
Total Current Assets	234.03	240.17	135.1	99.27	115.9	154.47
Net Property, Plant & Equipment	0.79	0.92	0.25	1.03	2.79	11.89
Other Intangible Assets	24.16	24.75	27.1	13.88	14.95	-
Other Long-Term Assets	245.64	247.76	1.53	3.06	0.64	0.97
Total Assets	504.61	513.59	163.98	117.23	134.28	167.33
Accounts Payable	4.49	7.19	3.34	7.14	22.51	3.8
Accrued Expenses	21.43	28.9	25.96	17.52	23.06	25.85
Current Portion of Long-Term Debt	29.87	29.81	7.27	7.23	-	-
Current Portion of Leases	0.64	0.61	0.29	0.69	1.13	9.89
Unearned Revenue	-	-	-	1.36	1.37	2.6
Other Current Liabilities	33.08	32.72	26.44	19.33	17.14	21.42
Total Current Liabilities	89.49	99.24	63.3	53.27	65.21	63.55
Long-Term Debt	14.99	22.48	52.41	52.37	39.45	19.91
Long-Term Leases	0.23	0.4	-	0.29	0.97	0.76
Other Long-Term Liabilities	-	-	44.98	39.94	42.26	52.73
Total Long-Term Liabilities	15.22	22.88	97.39	92.6	82.68	73.4
Total Liabilities	104.71	122.11	160.69	145.87	147.9	136.95
Common Stock	0.02	0.02	0.02	0.02	0.17	0.17
Additional Paid-in Capital	1,414	1,414	1,393	1,379	1,369	1,354
Accumulated Other Comprehensive Income	-0.13	0.18	0.01	0.01	-0.15	-0.1
Retained Earnings	-1,014	-1,023	-1,390	-1,408	-1,382	-1,324
Shareholders' Equity	399.9	391.48	3.29	-28.64	-13.62	30.37
Total Liabilities & Equity	504.61	513.59	163.98	117.23	134.28	167.33
Total Debt	45.72	53.3	59.97	60.58	41.55	30.57
Net Cash (Debt)	100.96	101.65	17.36	-3.65	16.65	94.4
Net Cash Growth	-0.68%	485.69%	-	-	-82.36%	417.56%
Net Cash Per Share	5.26	5.40	0.98	-0.21	0.98	5.54
Book Value	399.9	391.48	3.29	-28.64	-13.62	30.37
Book Value Per Share	20.83	20.78	0.19	-1.65	-0.80	1.78
Tangible Book Value	375.74	366.73	-23.81	-42.52	-28.57	30.37
Tangible Book Value Per Share	19.57	19.47	-1.35	-2.44	-1.68	1.78

Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q